MoneyWorks4Me

Ind-Swift Laboratories informs about board meeting

06 Aug 2013 Evaluate

Ind-Swift Laboratories has informed that a meeting of the Board of Directors of the company will be held on August 09, 2013 to consider the Quarterly Unaudited Financial Results (Provisional) for the quarter ended June 30, 2013 and the issue of shares on preferential basis to Promoter Directors and Promoters Group company in terms of the CDR package as sanctioned to the company by the Corporate Debt Restructuring Cell.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..